Evidence map›Paper›PMID 20177591›Full record

ReviewChemical communications (Cambridge, England)2010

Bioorthogonal chemistry: recent progress and future directions.

Reyna K V Lim, Qing Lin

Abstract readReview
In one paragraph

Review in Chemical communications (Cambridge, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. GLUT5: structure, functions, diseases and potential applications.Acta biochimica et biophysica Sinica · 2023
    Review
  9. Review
  10. Article
  11. Transcriptome-wide profiling ofChemical science · 2022
    Article
  12. Review
  13. Contemporary Approaches for Site-Selective Dual Functionalization of Proteins.Angewandte Chemie (International ed. in English) · 2021
    Review
  14. Bioorthogonal chemistry.Nature reviews. Methods primers · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Hydrophilic azaspiroalkenes as robust bioorthogonal reporters.Chemical communications (Cambridge, England) · 2018
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Reyna K V LimDepartment of Chemistry, State University of New York at Buffalo, Buffalo, New York 14260-3000, USA.
Qing Lin

Funding

Development and Applications of Photoinducible Bioorthogonal ChemistryR01GM085092 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LIN, QING · 2009 to 2017
$2.8M
NIGMS NIH HHS GM085092NIGMS NIH HHS R01 GM085092
6 · The paper itself

Abstract

The ability to use covalent chemistry to label biomolecules selectively in their native habitats has greatly enhanced our understanding of biomolecular dynamics and function beyond what is possible with genetic tools alone. To attain the exquisite selectivity that is essential in this covalent approach a "bottom-up" two-step strategy has achieved many successes recently. In this approach, a bioorthogonal chemical functionality is built into life's basic building blocks-amino acids, nucleosides, lipids, and sugars-as well as coenzymes; after the incorporation, an array of biophysical probes are selectively appended to the tagged biomolecules via a suitable bioorthogonal reaction. While much has been accomplished in the expansion of non-natural building blocks carrying unique chemical moieties, the dearth of robust bioorthogonal reactions has limited both the scope and utility of this promising approach. Here, we summarize the recent progress in the development of bioorthogonal reactions and their applications in various biological systems. A major emphasis has been placed on the mechanistic and kinetic studies of these reactions with the hope that continuous improvements can be made with each reaction in the future. In view of the gap between the capabilities of the current repertoire of bioorthogonal reactions and the unmet needs of outstanding biological problems, we also strive to project the future directions of this rapidly developing field.

Indexed as

AnimalsBiochemistryBiologyHumansKinetics

Identifiers

PMID20177591
PMCPMC2914230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.